Advanced NanoTherapies (ANT) has achieved positive results in the first-in-human trial of their SirPlux Duo drug-coated balloon. They plan to conduct an early feasibility study in the US to further assess the efficacy and safety of this treatment for coronary lesions.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing